5 completed. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 5 |
Follow CIN-107: new trials by email Literature Review of CIN-107 trials Research Report on CIN-107
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension Baxdrostat, Placebo - Uncontrolled Hypertension | Phase 2 | Completed | AstraZeneca | 48 | 2024-06-10 | 2025-12-17 |
| A Study to Evaluate CIN-107 for the Treatment of Patients With Uncontrolled Hypertension and Chronic Kidney Disease CIN-107, Placebo - Uncontrolled Hypertension, Chronic Kidney Diseases | Phase 2 | Completed | AstraZeneca | 195 | 2022-04-29 | 2025-05-20 |
| Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 CIN-107 - Hypertension | Phase 2 | Completed | AstraZeneca | 175 | 2022-04-06 | 2024-12-16 |
| A Study of CIN-107 in Patients With Uncontrolled Hypertension CIN-107, Placebo - Uncontrolled Hypertension | Phase 2 | Completed | CinCor Pharma, Inc. | 249 | 2021-12-07 | 2023-08-01 |
| A Study of CIN-107 in Adults With Treatment-Resistant Hypertension (rHTN) CIN-107, Placebo - Resistant Hypertension | Phase 2 | Completed | CinCor Pharma, Inc. | 275 | 2020-10-12 | 2023-07-24 |
Hypertension (1) · Renal Insufficiency, Chronic (1)
AstraZeneca (3) · CinCor Pharma, Inc. (2)
United States (5)